5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology.
Maffei ME.
Int J Mol Sci. 2020 Dec 26;22(1):181. doi: 10.3390/ijms22010181.
Movement Disorders in Children.
Jain R, Pandey S, Raghav S.
Indian Pediatr. 2021 Sep 15;58(9):861-870. Epub 2021 May 20.
Overview of Movement Disorders Secondary to Drugs.
Rissardo JP, Vora N, Mathew B, Kashyap V, Muhammad S, Fornari Caprara AL.
Clin Pract. 2023 Aug 18;13(4):959-976. doi: 10.3390/clinpract13040087.
Myoclonus: current concepts and recent advances.
Caviness JN, Brown P.
Lancet Neurol. 2004 Oct;3(10):598-607. doi: 10.1016/S1474-4422(04)00880-4.
Tardive Dystonia.
Skidmore F, Reich SG.
Curr Treat Options Neurol. 2005 May;7(3):231-236. doi: 10.1007/s11940-005-0016-0.
Three Cases of Myoclonus Secondary to Ciprofloxacin: "Ciproclonus".
Javed H, Ali HT, Soliman ZA, Caprara ALF, Rissardo JP.
Clin Neuropharmacol. 2023 Sep-Oct 01;46(5):200-203. doi: 10.1097/WNF.0000000000000565. Epub 2023 Jul 26.
Myoclonus status revealing COVID 19 infection.
Ben Mohamed D, Zouari R, Ketata J, Nabli F, Blel S, Ben Sassi S.
Seizure. 2023 Jan;104:12-14. doi: 10.1016/j.seizure.2022.11.010. Epub 2022 Nov 22.
Cortical myoclonus during lithium exposure.
Caviness JN, Evidente VG.
Arch Neurol. 2003 Mar;60(3):401-4. doi: 10.1001/archneur.60.3.401.
Anaesthetic and sedative agents used for electrical cardioversion.
Lewis SR, Nicholson A, Reed SS, Kenth JJ, Alderson P, Smith AF.
Cochrane Database Syst Rev. 2015 Mar 22;2015(3):CD010824. doi: 10.1002/14651858.CD010824.pub2.
Adverse motor effects induced by antiepileptic drugs.
Zaccara G, Cincotta M, Borgheresi A, Balestrieri F.
Epileptic Disord. 2004 Sep;6(3):153-68.
